MucoRice-ARP1

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMucoRice-ARP1
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody)
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsRotavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of TokyoUnilever
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUnileverUniversity Of Tokyo
Active IndicationsN/A
Inactive IndicationsRotavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A